INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML
Product details
Registration number: SIN15186P
Classification: Prescription Only
Active ingredients: paliperidone palmitate 273mg eqv paliperidone
Strength: 175mg/0.875ml
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: INTRAMUSCULAR
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
ATC code: N05AX13
HSA approval date: 6 March 2017
Manufacturer(s): Janssen Pharmaceutica NV, Beerse
Manufacturing country/countries: BELGIUM
What are the HSA registration number and classification for INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15186P
Classification: Prescription Only
What active ingredients and strength are recorded for INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: paliperidone palmitate 273mg eqv paliperidone
Strength: 175mg/0.875ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: INTRAMUSCULAR
Who is the recorded registrant for INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML?
According to the HSA dataset updated 7 August 2026:
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Janssen Pharmaceutica NV, Beerse
Manufacturing country/countries: BELGIUM
Where can I look up INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15186P or the exact product name INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML. The general register link does not preselect this product.
What are the source dates for this INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this INVEGA TRINZA PROLONGED RELEASE SUSPENSION FOR IM INJECTION 175MG/0.875ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15186P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)